Medical research charities contribute over £1 billion to health research in the UK. Many are increasingly looking to commercialise their research.
LifeArc, with its unique in-house expertise and knowledge, is well placed to help your charity overcome the challenges of translating research and maximise opportunities for patients and beneficiaries.
To date we have created a “Dementia Consortium” to identify and progress dementia drug targets. We recently launched the Neurodegeneration Medicines Acceleration Program, a consortium of global charities to accelerate parked pharma programs.